Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes
    • The Product Book

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data and AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma and Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
    • Content Hubs
Subscribe
Subscribe

False

The Analytical Scientist / Issues / 2026 / March / Mapping Molecular Discordance in the Brain
Omics Proteomics News and Research Mass Spectrometry Translational Science

Mapping Molecular Discordance in the Brain 

Single-cell proteomics reveals cell-type-specific regulation invisible to RNA-based methods 

03/03/2026 2 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Top Institutions

Share

Objective:

To create a detailed protein-level map of the developing human brain and investigate the discrepancies between gene expression and protein abundance, highlighting their significance for neurodevelopmental disorders.

Key Findings:
  • Extensive discordance between transcripts and proteins across nearly all cell types, with implications for understanding neurodevelopmental disorders.
  • Post-transcriptional regulation plays a central role in defining cellular identity during brain development.
  • Protein abundance is more cell-type-specific than mRNA levels, suggesting a need to focus on protein data in developmental studies.
  • Distinct protein co-expression modules emerged during the transition from intermediate progenitor cells to excitatory neurons, highlighting critical developmental processes.
  • High-risk genes for autism spectrum disorders showed high transcript levels but constrained protein abundance, indicating potential regulatory mechanisms.
Interpretation:

The findings suggest that protein regulation is crucial during early neurogenesis and may contribute to neurodevelopmental disorders, emphasizing the need for further research in this area.

Limitations:
  • The study focused on specific gestational weeks and may not represent the entire developmental spectrum, potentially limiting the generalizability of the findings.
  • Further research is needed to extend findings to disease tissue and other developmental stages to fully understand the implications.
Conclusion:

Single-cell proteomics can enhance understanding of genetic risk and regulatory control in brain development, potentially informing neurodevelopmental disorder research and guiding future studies.

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

Related Content

The Analytical Scientist Innovation Awards 2024: #7
Omics
The Analytical Scientist Innovation Awards 2024: #7

December 2, 2024

4 min read

Frank Steemers, co-founder and CSO of Scale Biosciences, tells us the story of ScalePlex – the 7th ranked innovation on this year’s Awards

The Analytical Scientist Innovation Awards 2024: #4
Omics
The Analytical Scientist Innovation Awards 2024: #4

December 5, 2024

6 min read

Thermo Fisher Scientific’s high-sensitivity mass spec for translational omics research – the Stellar MS – is ranked 4th in our annual Innovation Awards

Let Me See That Brain
Omics
Let Me See That Brain

December 9, 2024

1 min read

TRISCO sets a new standard for 3D RNA imaging, delivering high-resolution and uniform images to offer insights into brain function and anatomy

The Analytical Scientist Innovation Awards 2024
Omics
The Analytical Scientist Innovation Awards 2024

December 11, 2024

10 min read

Meet the products – and the experts – defining analytical innovation in 2024

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.